Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|November 8, 2021
The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-AnalysisZaiwei Song, Yang Hu, Shuang Liu, et al.
International Journal of Rheumatic Diseases|July 10, 2024
Do rheumatic diseases, long-term glucocorticoids, and immunosuppressant treatment, and vaccination impact the COVID-19 severity? Insight from a retrospective cohort studyYi Ma, Chang Wei, Zixi Yi, et al.
Frontiers in Public Health|January 28, 2022
Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical RecommendationsZaiwei Song, Yang Hu, Zhenyu Ren, et al.
Therapeutic Advances in Medical Oncology|May 30, 2024
Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic reviewXinya Li, Zaiwei Song, Zhanmiao Yi, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2024
Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposalXinya Li, Zaiwei Song, Yixuan Chen, et al.
Expert Review of Clinical Pharmacology|October 17, 2024
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysisYang Hu, Zaiwei Song, Yuan Gao, et al.
Expert Review of Clinical Pharmacology|September 21, 2024
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysisYang Hu, Zaiwei Song, Yuan Gao, et al.
European Journal of Clinical Pharmacology|April 8, 2025
Efficacy of cyclophosphamide for skin fibrosis in systemic sclerosis: a systematic review and single-arm meta-analysisXin Tian, PengJiao An, RongJi Liu, et al.
Analytical and Bioanalytical Chemistry|December 20, 2024
Development, validation, and clinical application of LC-MS/MS method for simultaneous determination of ibrutinib, zanubrutinib, orelabrutinib, acalabrutinib, and their active metabolites in patients with B-cell lymphomaDan Jiang, Zaiwei Song, Yi Ma, et al.
Frontiers in Pharmacology|July 11, 2022
Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety RelationshipZaiwei Song, Lan Ma, Li Bao, et al.
Pageof 3